GlassScriptPhysician profile
Jon A Reese
NPI 1922171966
$1,547.68
in general payments reported to CMS, 2019-2025
19 companies · $303 in 2025
The $303 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $127 · 2022: $33.54 · 2023: $466 · 2024: $127 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $895.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $292.66 | 2023-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Ge Healthcare | $277.77 | 2019 | |
| Abbott Laboratories | $211.88 | 2023-2025 | Esprit, Diamondback Peripheral |
| Medtronic, INC. | $166.92 | 2023-2024 | Venaseal, Closurefast |
| Silk Road Medical, INC. | $144.33 | 2019-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Tactile Systems Technology INC | $77.68 | 2019 | |
| Endologix LLC | $73.93 | 2019 | |
| Cardiovascular Systems INC. | $63.31 | 2020 | |
| Lemaitre Vascular, INC. | $45.06 | 2024 | Artegraft Vascular Graft |
| Bard Peripheral Vascular, INC. | $36.79 | 2022-2025 | Rotarexs 6 F X 135 Cm |
| Acera Surgical, INC. | $23.73 | 2023 | Restrata Wound Matrix |
| Avinger INC. | $23.13 | 2019 | |
| Boston Scientific Corporation | $21.45 | 2020 | |
| Amgen INC. | $17.92 | 2024 | Repatha |
| Janssen Pharmaceuticals, INC | $16.87 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $16.87 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Portola Pharmaceuticals, LLC | $13.90 | 2020 | |
| Atricure, INC. | $12.48 | 2022 | |
| Penumbra, INC. | $11.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Reese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.